Meeting
2015 Genitourinary Cancers Symposium
Frailty as a marker of adverse outcomes during cystectomy for urothelial cancer.
Authors
Max Kates
The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD
Max Kates , Hiten Patel , Nikolai Sopko , Jen-Jane Liu , Phillip M Pierorazio , Trinity Bivalacqua
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 374)
DOI
10.1200/jco.2015.33.7_suppl.374
Abstract #
374
Poster Bd #
H11
Abstract Disclosures
Similar Posters
First Author: Kevin Joseph Chua
Poster
2023 ASCO Annual Meeting
The association of the comorbidity polypharmacy score (CPS) with functional limitations, frailty, and mortality in older adults with gastrointestinal malignancies.
First Author: Brian Westbrook
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of neoadjuvant chemotherapy on 30-day radical cystectomy outcomes.
First Author: Rishabh Kumar Simhal
Poster
2022 ASCO Annual Meeting
Association of frailty with clinical and financial outcomes of allogeneic hematopoietic stem cell transplant.
First Author: Sara Sakowitz